Table 1.

Effect of Peptides on PE Binding to Immobilized Proteins and Cells

Peptides Concentration (μg/mL)PE Binding (% of control)
Targets
CSA-BSA CD36 CD36-CHO Cell TSP C32 Cell
None  —  100  100  100 100  100  
LF peptide  10  76.1 ± 11.3 ND  ND  75.2 ± 13.5  ND 
 20  42.6 ± 1.2  ND  ND 68.0 ± 8.7  ND  
 50  41.2 ± 20.9 ND  77.3 ± 10.7  30.8 ± 2.6 68.1 ± 28.9  
 100  38.0 ± 14.4  85.8 ± 32.7 49.0 ± 5.0  38.2 ± 4.4  39.5 ± 14.6  
 200 ND  79.6 ± 26.4  ND  20.1 ± 6.7 ND  
 500  20.7 ± 1.9  58.0 ± 5.6 47.8 ± 8.1  ND  43.7 ± 8.8  
 1,000 21.9 ± 10.1  34.9 ± 20.3  50.6 ± 10.4 ND  37.2 ± 10.9  
FASP peptide  1,000 93.2 ± 16.9  107.6 ± 13.3  107.6 ± 30.0 98.4 ± 2.3  93.7 ± 12.4  
KPSE peptide  1,000 90.0 ± 18.7  106.6 ± 10.1  98.2 ± 14.7 95.5 ± 10.7  108.3 ± 27.4 
Peptides Concentration (μg/mL)PE Binding (% of control)
Targets
CSA-BSA CD36 CD36-CHO Cell TSP C32 Cell
None  —  100  100  100 100  100  
LF peptide  10  76.1 ± 11.3 ND  ND  75.2 ± 13.5  ND 
 20  42.6 ± 1.2  ND  ND 68.0 ± 8.7  ND  
 50  41.2 ± 20.9 ND  77.3 ± 10.7  30.8 ± 2.6 68.1 ± 28.9  
 100  38.0 ± 14.4  85.8 ± 32.7 49.0 ± 5.0  38.2 ± 4.4  39.5 ± 14.6  
 200 ND  79.6 ± 26.4  ND  20.1 ± 6.7 ND  
 500  20.7 ± 1.9  58.0 ± 5.6 47.8 ± 8.1  ND  43.7 ± 8.8  
 1,000 21.9 ± 10.1  34.9 ± 20.3  50.6 ± 10.4 ND  37.2 ± 10.9  
FASP peptide  1,000 93.2 ± 16.9  107.6 ± 13.3  107.6 ± 30.0 98.4 ± 2.3  93.7 ± 12.4  
KPSE peptide  1,000 90.0 ± 18.7  106.6 ± 10.1  98.2 ± 14.7 95.5 ± 10.7  108.3 ± 27.4 

Spots of immobilized proteins and cells were pretreated with the indicated concentrations of peptide solutions, and the pretreatment solutions were removed before cytoadherence assay. Cytoadherence assays were conducted as described under Materials and Methods and in the legends of Figs 1, 2, 5, and 7. Each value represents the mean ± SD of triplicate determinations.

Abbreviation: ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal